THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets
暂无分享,去创建一个
Stephen P. H. Alexander | C. Southan | D. Fabbro | A. Christopoulos | M. Spedding | A. Mathie | J. Cidlowski | J. Davies | K. Druey | T. Arumugam | C. Sobey | J. Armstrong | E. Faccenda | S. Harding | A. Davenport | J. A. Peters | B. Chakravarti | R. Fisher | Havish S. Kantheti | Zili Luo | Kyle J Gerber | Katherine E Squires | J. Hepler | K. Martemyanov | A. J. Pawson | T. Wilkie | E. Kelly | J. Striessnig | K. Ahlers-Dannen | D. Roman | Behirda Karaj | Vincent S. Shaw | E. Veale | Christopher R Bodle | Jae-Kyung Lee | S. Hooks | Osita W. Ogujiofor | L. Sutton | Carolina Montañez-Miranda | Keqiang Xie | H. Phan | Menbere Y. Wendimu | Mohammed Alqinyah | Qian Zhang | Yalda Zolghadri | O. Buneman | K. Ahlers‐Dannen | Josephine Buo Dagner | S. P. Choudhuri | Somayeh Layeghi-Ghalehsoukhteh | Luke D. Mascarenhas | Harrison J. McNabb | Benita Sjogren | M. Spicer | Adam J. Pawson | Menbere Y Wendimu | Mackenzie M. Spicer
[1] D. Passarella,et al. Microtubule-targeting agents and neurodegeneration. , 2020, Drug discovery today.
[2] V. Summa,et al. Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities , 2020, Journal of medicinal chemistry.
[3] C. Southan,et al. A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development: IUPHAR Review 29 , 2020, British journal of pharmacology.
[4] Alain Le Coupanec,et al. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? , 2019, Viruses.
[5] E. Nogales,et al. Effects of α-tubulin acetylation on microtubule structure and stability , 2019, Proceedings of the National Academy of Sciences.
[6] Chuan Qin,et al. From SARS to MERS, Thrusting Coronaviruses into the Spotlight , 2019, Viruses.
[7] Zhènglì Shí,et al. Origin and evolution of pathogenic coronaviruses , 2018, Nature Reviews Microbiology.
[8] Carsten Janke,et al. Tubulin Posttranslational Modifications and Emerging Links to Human Disease , 2018, Cell.
[9] Diego Bonatto,et al. Anti‐mitotic agents: Are they emerging molecules for cancer treatment?☆ , 2017, Pharmacology & therapeutics.
[10] Carsten Janke,et al. The tubulin code at a glance , 2017, Journal of Cell Science.
[11] Alimuddin Zumla,et al. Coronaviruses — drug discovery and therapeutic options , 2016, Nature Reviews Drug Discovery.